KPIs & Operating Metrics(New)
Breakdown Of AssetsCommercial Revenue BreakdownCost Of SalesEmployee StatisticsGross Margin %Gross ProfitIncome Before Provisions For Income TaxesOperating Expense SegregationOpex As A % Of RevenueProfitabilityProfitability %Profitability AnnualProfitability Annual %Property, Plant And Equipment BreakdownRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Contracts With CustomerRevenue By Contracts With Customer %Revenue By Countries AnnualRevenue By Countries Annual %Revenue By Customers AnnualRevenue By Customers Annual %Revenue By Timing Of RecognitionRevenue By Timing Of Recognition %Revenue By Timing Of Recognition AnnualRevenue By Timing Of Recognition Annual %Total Revenue Breakdown
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Gross Profit (2018 - 2025)

Historic Gross Profit for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $1.6 billion.

  • BioNTech SE's Gross Profit rose 3688.0% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 515.99%. This contributed to the annual value of $2.4 billion for FY2024, which is 3182.42% down from last year.
  • BioNTech SE's Gross Profit amounted to $1.6 billion in Q3 2025, which was up 3688.0% from $208.7 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Gross Profit ranged from a high of $5.8 billion in Q3 2021 and a low of $5.2 million during Q2 2023
  • For the 5-year period, BioNTech SE's Gross Profit averaged around $2.2 billion, with its median value being $1.4 billion (2023).
  • The largest annual percentage gain for BioNTech SE's Gross Profit in the last 5 years was 1330084.73% (2021), contrasted with its biggest fall of 9999.84% (2021).
  • BioNTech SE's Gross Profit (Quarter) stood at $5.7 billion in 2021, then decreased by 26.21% to $4.2 billion in 2022, then crashed by 66.52% to $1.4 billion in 2023, then decreased by 27.68% to $1.0 billion in 2024, then soared by 58.42% to $1.6 billion in 2025.
  • Its Gross Profit was $1.6 billion in Q3 2025, compared to $208.7 million in Q2 2025 and $104.1 million in Q1 2025.